Coronary Guidewires - Medical Devices Pipeline Assessment, 2017

Coronary Guidewires - Medical Devices Pipeline Assessment, 2017

Summary

GlobalDatas Medical Devices sector report, Coronary Guidewires - Medical Devices Pipeline Assessment, 2017" provides an overview of Coronary Guidewires currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Guidewires pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalDatas team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Coronary Guidewires under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Coronary Guidewires and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Coronary Guidewires under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Coronary Guidewires Overview 7
3 Products under Development 8
3.1 Coronary Guidewires - Pipeline Products by Stage of Development 8
3.2 Coronary Guidewires - Pipeline Products by Territory 9
3.3 Coronary Guidewires - Pipeline Products by Regulatory Path 10
3.4 Coronary Guidewires - Pipeline Products by Estimated Approval Date 11
4 Coronary Guidewires - Pipeline Products under Development by Companies 12
4.1 Coronary Guidewires Companies - Pipeline Products by Stage of Development 12
4.2 Coronary Guidewires - Pipeline Products by Stage of Development 13
5 Coronary Guidewires Companies and Product Overview 14
5.1 Bioscan Technologies Inc. Company Overview 14
5.1.1 Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Blueacre Technology Limited Company Overview 15
5.2.1 Blueacre Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Boston Scientific Corp Company Overview 16
5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 CardioSert Ltd. Company Overview 17
5.4.1 CardioSert Ltd. Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 ENDOMATERIALS Company Overview 18
5.5.1 ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview 18
5.6 Georgia Institute of Technology Company Overview 19
5.6.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 19
5.7 Guided Interventions, LLC Company Overview 20
5.7.1 Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.8 JRjr33, Inc. Company Overview 21
5.8.1 JRjr33, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.9 MaRVis Technologies GmbH Company Overview 23
5.9.1 MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 23
5.10 MicroPort Scientific Corp Company Overview 25
5.10.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 25
5.11 Occlutech International AB Company Overview 26
5.11.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview 26
5.12 OVALUM Ltd Company Overview 27
5.12.1 OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
5.13 St. Jude Medical LLC Company Overview 28
5.13.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.14 Terumo Corp Company Overview 29
5.14.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 29
5.15 The Cleveland Clinic Foundation Company Overview 30
5.15.1 The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 30
5.16 University of Illinois at Chicago Company Overview 31
5.16.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 31
5.17 Vasostar Ltd. Company Overview 32
5.17.1 Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview 32
6 Coronary Guidewires- Recent Developments 33
6.1 May 26, 2017: Merit Medical Announces Appointment of New Director 33
6.2 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 33
6.3 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 36
6.4 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 37
6.5 Apr 19, 2017: Abbott Reports First-Quarter 2017 Results 38
6.6 Apr 19, 2017: Opsens Reports Q2 2017 Results - Quarterly Consolidated Revenues Up 75% to $4.8 Million 41
6.7 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 42
6.8 Mar 31, 2017: B. Braun continues its sales and earnings growth 42
6.9 Mar 30, 2017: AngioDynamics Reports Fiscal 2017 Third Quarter Results 44
6.10 Mar 30, 2017: MPSC Announces 2016 Annual Results 45
6.11 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 47
6.12 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 47
6.13 Feb 22, 2017: Change in the B. Braun Management Board 48
6.14 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 48
6.15 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 51
6.16 Feb 09, 2017: Terumo Announces Change of Executive Officers 52
6.17 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 53
6.18 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 54
6.19 Jan 31, 2017: Terumo Opens a Branch in Yangon 55
6.20 Jan 26, 2017: Opsens Reports Q1 2017 Results - Focused Execution Leads to Record Quarterly Revenues 56
6.21 Jan 12, 2017: Anteo Diagnostics Strengthening its Intellectual Property Position in Medical Device Arena 57
6.22 Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results 57
6.23 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 59
6.24 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 59
6.25 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 62
6.26 Nov 16, 2016: Opsens Reports Results for 2016-Record Total Revenues Driven by Tenfold Increase in FFR Sales 63
6.27 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 64
6.28 Nov 09, 2016: AngioDynamics Announces Addition of New Board Members 65
6.29 Nov 03, 2016: DSM Q3 2016 Results 65
6.30 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 68
6.31 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 69
6.32 Oct 24, 2016: St. Jude Medical Announces Data to be Presented as Late-Breaking Clinical Trials and Highlights Its Latest Cardiovascular Portfolio at the 2016 TCT Conference 70
6.33 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 71
6.34 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 74
6.35 Oct 12, 2016: Hydromer Announces Entering Into 2 Coating Service Agreements Leveraging Its Medical Device Subsidiary, Biosearch Medical Products 75
6.36 Oct 10, 2016: St. Jude Medical Announces FDA Clearance and Launch of the New PressureWire X Guidewire Designed to Optimize PCI Procedures in Patients With Complex Anatomies 76
6.37 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 77
6.38 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results 78
6.39 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 79
6.40 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 80
6.41 Aug 30, 2016: MPSC Announces 2016 Interim Results 80
6.42 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 82
6.43 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 85
6.44 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 86
6.45 Jul 26, 2016: Merit Medical Announces Appointment of New Director 87
6.46 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer 88
6.47 Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results 88
6.48 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 91
6.49 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 92
6.50 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results 93
6.51 Jul 05, 2016: Opsens Announces Fiscal 2016 Third Quarter Results - Sales Of $2,125,000, Up 156% Year-Over-Year 94
6.52 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 95
6.53 Jun 22, 2016: Opsens receives Health Canada approval for the sale of OptoWire II 96
7 Appendix 97
7.1 Methodology 97
7.2 About GlobalData 100
7.3 Contact Us 100
7.4 Disclaimer 100

List Of Tables

Table 1: Coronary Guidewires - Pipeline Products by Stage of Development 8
Table 2: Coronary Guidewires - Pipeline Products by Territory 9
Table 3: Coronary Guidewires - Pipeline Products by Regulatory Path 10
Table 4: Coronary Guidewires - Pipeline Products by Estimated Approval Date 11
Table 5: Coronary Guidewires Companies - Pipeline Products by Stage of Development 12
Table 6: Coronary Guidewires - Pipeline Products by Stage of Development 13
Table 7: Bioscan Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
Table 8: Lightwire - Product Status 14
Table 9: Lightwire - Product Description 14
Table 10: Blueacre Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 15
Table 11: Next Generation Guide Wire - Product Status 15
Table 12: Next Generation Guide Wire - Product Description 15
Table 13: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16
Table 14: Crossing Wire - Product Status 16
Table 15: Crossing Wire - Product Description 16
Table 16: CardioSert Ltd. Pipeline Products & Ongoing Clinical Trials Overview 17
Table 17: Versatile Guidewire - Product Status 17
Table 18: Versatile Guidewire - Product Description 17
Table 19: ENDOMATERIALS Pipeline Products & Ongoing Clinical Trials Overview 18
Table 20: Multimodal Sensing Guidewire - Product Status 18
Table 21: Multimodal Sensing Guidewire - Product Description 18
Table 22: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 19
Table 23: Intravascular Ultrasound Imaging Guidewire - Product Status 19
Table 24: Intravascular Ultrasound Imaging Guidewire - Product Description 19
Table 25: Guided Interventions, LLC Pipeline Products & Ongoing Clinical Trials Overview 20
Table 26: Pressure Sensing Coronary Artery Guide Wire - Product Status 20
Table 27: Pressure Sensing Coronary Artery Guide Wire - Product Description 20
Table 28: JRjr33, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 29: Maneuverable Coiled Guidewire - Product Status 21
Table 30: Maneuverable Coiled Guidewire - Product Description 21
Table 31: Steerable Guidewire - Product Status 22
Table 32: Steerable Guidewire - Product Description 22
Table 33: MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 23
Table 34: MaRVis 0.014 Micro Guidewire - Product Status 23
Table 35: MaRVis 0.014 Micro Guidewire - Product Description 23
Table 36: MaRVis 0.035" Standard And Stiff Guidewire - Product Status 24
Table 37: MaRVis 0.035" Standard And Stiff Guidewire - Product Description 24
Table 38: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 25
Table 39: Micro-Guide Wire - Product Status 25
Table 40: Micro-Guide Wire - Product Description 25
Table 41: Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview 26
Table 42: Occlutech Stiff Guide Wire - Product Status 26
Table 43: Occlutech Stiff Guide Wire - Product Description 26
Table 44: OVALUM Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
Table 45: OctoBooster Extension Guidewire - Product Status 27
Table 46: OctoBooster Extension Guidewire - Product Description 27
Table 47: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 28
Table 48: Sensor Enabled - Quadra Excel Guidewire - Product Status 28
Table 49: Sensor Enabled - Quadra Excel Guidewire - Product Description 28
Table 50: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 29
Table 51: Wrist Artery Guidewire - Product Status 29
Table 52: Wrist Artery Guidewire - Product Description 29
Table 53: The Cleveland Clinic Foundation Pipeline Products & Ongoing Clinical Trials Overview 30
Table 54: CTO Guidewire - Product Status 30
Table 55: CTO Guidewire - Product Description 30
Table 56: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 31
Table 57: CTO Wire - Product Status 31
Table 58: CTO Wire - Product Description 31
Table 59: Vasostar Ltd. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 60: Vibrational Guidewire System - Product Status 32
Table 61: Vibrational Guidewire System - Product Description 32
Table 62: Glossary 99

List Of Figures

Figure 1: Coronary Guidewires - Pipeline Products by Stage of Development 8
Figure 2: Coronary Guidewires - Pipeline Products by Territory 9
Figure 3: Coronary Guidewires - Pipeline Products by Regulatory Path 10
Figure 4: Coronary Guidewires - Pipeline Products by Estimated Approval Date 11

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available